GILDER GAGNON HOWE & CO LLC 13D and 13G filings for Flexion Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2020-02-14 10:19 am Sale | 2019-12-31 | 13G | Flexion Therapeutics, Inc. FLXN | GILDER GAGNON HOWE & CO LLC | 429,255 1.120% | -1,960,705 (-82.04%) | Filing |